An observational study in Acute Low Back Pain, sponsored by International Institute of Behavioral Medicines. Completed at 1 site in Italy. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-02-06.
Sponsored by International Institute of Behavioral Medicines · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 56 studies in Low Back Pain with a site in Italy — 12 open to participants now, 13 under way, 1 of them phase 3. Low Back Pain · Italy.
Among the 56 studies in Low Back Pain with a site in Italy, this one is the 9th largest by enrollment of the 15 observational ones that give a count, is one of 7 that started in 2023, is one of 16 observational ones, and was the 44th registered.
2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.
Browse Low Back Pain studies →12 of the 56 studies in Low Back Pain with a site in Italy are open now. Recruiting first, the newest first:
Istituti Clinici Scientifici Maugeri SpA · Sites in Italy
Ages 18–90
Manusapiens · Sites in Italy
Ages 20–40 · Women only · Healthy volunteers
Fondazione Don Carlo Gnocchi Onlus · Sites in Italy
Ages 18+
International Institute of Behavioral Medicines · Sites in Italy
Ages 11–30
International Institute of Behavioral Medicines · Sites in Italy
Ages 18+
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
56 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 6 · Phase 3 5 · Phase 4 7
First in 2005; this study’s year is marked. 7 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 100 is close to the median of 100 across 484 observational studies indexed under Low Back Pain.
Median enrollment 67 across the 40 interventional studies, 104 across the 15 observational. Of the 34 that completed or were terminated, 4 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 56 have an industry lead sponsor. The 10 most frequent:
International Institute of Behavioral Medicines is the lead sponsor of 6 studies on the registry; 4 are open to participants now.
International Institute of Behavioral Medicines has 4 studies filed under Low Back Pain — fewer than ten, so there is no comparison to draw.
2 of the studies in Low Back Pain with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07568353G. d'Annunzio UniversityBrain Connectivity and Perceptive Surfaces in Chronic Low Back Pain (SUPER-RMNf) | 2027-05-31 |
| NCT07647757Federico II UniversityNeurolyser XR for the Treatment of Sacroiliitis | 2027-07 |
Add all 2 to your calendar (.ics) → With an account.
Among the 56 studies in Low Back Pain with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is a behavioral observational study aimed at understanding the limit of tolerance (in days) of ideally performing a Magnetic Resonance Imaging (MRI) by people with acute low back pain. It consists of a short self-administered questionnaire. Relationships between low back pain intensity, maladaptive thoughts and awaited days before ideally requesting a MRI will be evaluated.
This is a behavioral observational study aimed at understanding the limit of tolerance (in days) of ideally performing a Magnetic Resonance Imaging (MRI) by people with acute low back pain (LBP) and by general practitioners (GP).
Literature pointed out that LBP is a common occurrence in people, with high rates of self-resolution in the absence of red flags (i.e. possible indicators of serious spinal pathology).
In Italy there is an over-prescription of MRI despite international guidelines go the opposite way.
The study consists of a short self-administered questionnaire which will be given to people and GP to complete. In more details, the survey is made of 3 questions collecting information on the limit of tolerance (in days) before requesting (people) and prescribing (GP) a MRI for the lumbar tract of the spinal column.
Further, participants will have to complete a self-administered pain intensity numerical rating scale, along with catastrophizing and anxiety self-administered questionnaires.
Descriptive statistics will be presented by taking into account the socio-demographic characteristics of the sample being investigated. Statistical correlations between participants' answers and the scores from the questionnaires will be also evaluated.
This study investigates the relationships among acute low back pain, the intention of persons/GP to request/prescribe a MRI despite the absence of red flags, mood disorders and maladaptive thoughts.
Adult people with acute low back pain (i.e., a pain lasting no more than 6 weeks).
General practitioners who are involved in the managment of people with acute low back pain.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
No intervention.
Other: The present study does not contain any intervention
No intervention.
Other: The present study does not contain any intervention
The present study does not contain any intervention
Two questions on limit of tolerance
Design of questions which investigates the limit of tolerance of requesting and prescribing a MRI; score is expressed as "number of days" (neither min nor max values are stated a priori).
Time frame: Up to the first day
NRS
pain intensity Numerical Rating Scale; score 0-10 with higher estimates indicating higher levels of pain intensity
Time frame: Up to the first day
PCS
Pain Catastrophizing Scale; score 0-52 with higher estimates indicating higher levels of catastrophizing.
Time frame: Up to the first day
ZUNG
Zung Self-Rating Anxiety Scale; score 20-80 with higher estimates indicating higher levels of anxiety
Time frame: Up to the first day
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2023 to primary completion in Dec 2023, 3 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
International Institute of Behavioral Medicines